Abstract
Human endometrial mesenchymal stem cells (hEMSCs) have been shown to promote neo-vascularization; however, its angiogenic function lessens with age. To determine the optimal conditions for maximizing hEMSC angiogenic capacity, we examined the effects of serial passaging on hEMSC activity. hEMSCs were cultured from passages (P) 3, 6, 9, and 12, and analyzed for proliferation, migration, differentiation and senescence, as well as their capacity to induce angiogenesis. The results showed that hEMSC proliferation and migration significantly decreased after P12. Furthermore, hEMSC differentiation into adipogenic and osteogenic lineages, as well as their proangiogenic capacity, gradually decreased from P9-12, while senescence only occurred after P12. Evaluation of angiogenic-related protein levels showed that both transforming growth factor β2 and Tie-2 was significantly reduced in hEMSCs at P12, compared to P3, possibly serving as the basis behind their lowered angiogenic capacity. Furthermore, in vivo angiogenesis evaluation with Matrigel plug assay showed that the optimal hEMSC to HUVEC ratio, for maximizing vessel formation, was 1:4. This study showed that hEMSC passaging was associated with lowered cellular functioning, bringing them closer to a senescent phenotype, especially after P12, thereby defining the optimal time period for cultivating fully functional hEMSCs for therapeutic applications.
Similar content being viewed by others
Data availability
The data presented in this study are available on request from the corresponding author.
References
Vodyanik MA, Yu J, Zhang X, Tian S, Stewart R, Thomson JA, Slukvin II (2010) A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell 7:718–729. https://doi.org/10.1016/j.stem.2010.11.011
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147. https://doi.org/10.1126/science.284.5411.143
Sierra Parraga JM, Rozenberg K, Eijken M, Leuvenink HG, Hunter J, Merino A, Moers C, Moller BK, Ploeg RJ, Baan CC, Jespersen B, Hoogduijn MJ (2019) Effects of normothermic machine perfusion conditions on mesenchymal stromal cells. Front Immunol 10:765. https://doi.org/10.3389/fimmu.2019.00765
Fossett E, Khan WS (2012) Optimising human mesenchymal stem cell numbers for clinical application: a literature review. Stem Cells Int 2012:465259. https://doi.org/10.1155/2012/465259
Hasan A, Byambaa B, Morshed M, Cheikh MI, Shakoor RA, Mustafy T, Marei HE (2018) Advances in osteobiologic materials for bone substitutes. J Tissue Eng Regen Med 12:1448–1468. https://doi.org/10.1002/term.2677
Marofi F, Vahedi G, Hasanzadeh A, Salarinasab S, Arzhanga P, Khademi B, Farshdousti Hagh M (2019) Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: mirage or reality? J Cell Physiol 234:1268–1288. https://doi.org/10.1002/jcp.27152
Andrzejewska A, Lukomska B, Janowski M (2019) Concise review: mesenchymal stem cells: from roots to boost. Stem Cells 37:855–864. https://doi.org/10.1002/stem.3016
Xaymardan M, Sun Z, Hatta K, Tsukashita M, Konecny F, Weisel RD, Li RK (2012) Uterine cells are recruited to the infarcted heart and improve cardiac outcomes in female rats. J Mol Cell Cardiol 52:1265–1273. https://doi.org/10.1016/j.yjmcc.2012.03.002
Fan X, He S, Song H, Yin W, Zhang J, Peng Z, Yang K, Zhai X, Zhao L, Gong H, Ping Y, Jiao X, Zhang S, Yan C, Wang H, Li RK, Xie J (2021) Human endometrium-derived stem cell improves cardiac function after myocardial ischemic injury by enhancing angiogenesis and myocardial metabolism. Stem Cell Res Ther 12:344. https://doi.org/10.1186/s13287-021-02423-5
Gargett CE, Schwab KE, Deane JA (2016) Endometrial stem/progenitor cells: the first 10 years. Hum Reprod Update 22:137–163. https://doi.org/10.1093/humupd/dmv051
Si YL, Zhao YL, Hao HJ, Fu XB, Han WD (2011) MSCs: biological characteristics, clinical applications and their outstanding concerns. Ageing Res Rev 10:93–103. https://doi.org/10.1016/j.arr.2010.08.005
Mamidi MK, Nathan KG, Singh G, Thrichelvam ST, Mohd Yusof NA, Fakharuzi NA, Zakaria Z, Bhonde R, Das AK, Majumdar AS (2012) Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation. J Cell Biochem 113:3153–3164. https://doi.org/10.1002/jcb.24193
Stab BR 2nd, Martinez L, Grismaldo A, Lerma A, Gutierrez ML, Barrera LA, Sutachan JJ, Albarracin SL (2016) Mitochondrial functional changes characterization in young and senescent human adipose derived MSCs. Front Aging Neurosci 8:299. https://doi.org/10.3389/fnagi.2016.00299
Zhai XY, Yan P, Zhang J, Song HF, Yin WJ, Gong H, Li H, Wu J, Xie J, Li RK (2016) Knockdown of SIRT6 enables human bone marrow mesenchymal stem cell senescence. Rejuvenation Res 19:373–384. https://doi.org/10.1089/rej.2015.1770
Song HF, He S, Li SH, Yin WJ, Wu J, Guo J, Shao ZB, Zhai XY, Gong H, Lu L, Wei F, Weisel RD, Xie J, Li RK (2017) Aged human multipotent mesenchymal stromal cells can be rejuvenated by neuron-derived neurotrophic factor and improve heart function after injury. JACC Basic Transl Sci 2:702–716. https://doi.org/10.1016/j.jacbts.2017.07.014
Kapetanos K, Asimakopoulos D, Christodoulou N, Vogt A, Khan W (2021) Chronological age affects MSC senescence in vitro-a systematic review. Int J Mol Sci. https://doi.org/10.3390/ijms22157945
Nakazaki M, Morita T, Lankford KL, Askenase PW, Kocsis JD (2021) Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF-β upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury. J Extracell Vesicles. https://doi.org/10.1002/jev2.12137
Zhang C, Lin Y, Liu Q, He J, Xiang P, Wang D, Hu X, Chen J, Zhu W, Yu H (2020) Growth differentiation factor 11 promotes differentiation of MSCs into endothelial-like cells for angiogenesis. J Cell Mol Med 24:8703–8717. https://doi.org/10.1111/jcmm.15502
Xu K, Ma D, Zhang G, Gao J, Su Y, Liu S, Liu Y, Han J, Tian M, Wei C, Zhang L (2021) Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles ameliorate collagen-induced arthritis via immunomodulatory T lymphocytes. Mol Immunol 135:36–44. https://doi.org/10.1016/j.molimm.2021.04.001
Wu R, Liu C, Deng X, Chen L, Hao S, Ma L (2020) Enhanced alleviation of aGVHD by TGF-β1-modified mesenchymal stem cells in mice through shifting MΦ into M2 phenotype and promoting the differentiation of treg cells. J Cell Mol Med 24:1684–1699. https://doi.org/10.1111/jcmm.14862
Arck P, Solano ME, Walecki M, Meinhardt A (2014) The immune privilege of testis and gravid uterus: same difference? Mol Cell Endocrinol 382:509–520. https://doi.org/10.1016/j.mce.2013.09.022
Ludke A, Wu J, Nazari M, Hatta K, Shao Z, Li SH, Song H, Ni NC, Weisel RD, Li RK (2015) Uterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy. J Mol Cell Cardiol 84:116–128. https://doi.org/10.1016/j.yjmcc.2015.04.019
Funding
This work was supported by a grant from the National Natural Science Foundation of China (81702239), Key R&D program of Shanxi Province (International cooperation, 201903D421023), Shanxi Scholarship Council of China (2021–078), the Natural Science Foundation for Young Scientists of Shanxi Province (201901D211533, 201901D211324).
Author information
Authors and Affiliations
Contributions
JZ performed the experiments, analyzed the data, and wrote the manuscript. HS, XF, SH, WY, ZP, XZ, KY, HG, ZW, YP and SZ assisted with data acquisition and analysis. RL and JX conceived and designed the experiments. All authors have read and approved the manuscript.
Corresponding authors
Ethics declarations
Conflicts of interest
The authors declare no conflict of interest.
Ethical approval
The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Research Ethics Board (REB#: 2018026) of Shanxi Medical University and the Hospital's Ethics Committee.
Consent to human and animal participate
All animal experiments were approved by the institutional animal use and care committee of Shanxi Medical University, and carried out in accordance with the Guide for the Care and Use of Laboratory Animals (NIH, 8th Edition, 2011).
Consent to participate
All subjects gave their written informed consent for inclusion prior to participation in the study.
Consent for publication
Not Applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Handling Editor: Naranjan Dhalla
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, J., Song, H., Fan, X. et al. Optimizing human endometrial mesenchymal stem cells for maximal induction of angiogenesis. Mol Cell Biochem 478, 1191–1204 (2023). https://doi.org/10.1007/s11010-022-04572-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-022-04572-4